AUG 15, 2019 9:00 AM PDT

Understanding and ameliorating radiation-induced damage to oligodendrocytes

Speaker
  • Postdoctoral Fellow, Georgetown University
    Biography
      Dr. Alexandra Taraboletti is a postdoctoral fellow training in the Tumor Biology program funded through a T32 Ruth L. Kirschstein National Research Service Award at Georgetown University Lombardi Comprehensive Cancer Center. Dr. Taraboletti received her PhD from the University of Akron in Chemistry where she used mass spectrometry-based metabolomics to investigate models neurodegeneration in multiple sclerosis and myelin biology. In Dr. Fornace's lab, Alexandra applies metabolomics to assess biomarkers in easily accessible fluids following radiation injury. Specifically, she has worked on a new technology development for metabolomic-based biodosimetry, and is exploring protection methods to counter the negative impact of radiation in the brain. She uses a cell culture model of the myelin producing oligodendrocyte cell to examine in vitro effects of radiation. She is currently testing the use of dimethyl fumarate as a neuroprotectant against radiation injury. At Georgetown, Dr. Taraboletti is a Co-Chair for the Georgetown Postdoc Association - an establishment that acts to foster camaraderie and organize career development activities specifically geared towards postdocs. Her work with the Georgetown Postdoc Association has led to the developing stages of a new workshop series she hope to develop. The series hopes to foster teaching/higher education skills in interested graduate students and postdoctoral fellows. Dr. Taraboletti, also has a passion for visual science communication, and applies her skills at the graphical editor and illustrator for The POSTDOCket (the newsletter of the National Postdoctoral Association). She is an avid artist, and is always looking to grow in the bourgeoning field of #sciart.

    Abstract
    DATE:  August 15, 2019
    TIME:   9:00am PDT, 12:00pm EDT
     
     
    Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation (IR) causes numerous central nervous system side-effects, including declines in cognitive function, memory, and attention. Brain injury from IR is characterized by numerus inflammatory effects, including white matter damage from the loss of myelin-producing oligodendrocyte cells. While neuro-oncology outcomes are often concerned with survival, strategies to understand and ameliorate radiation-induced damage after IR treatment are needed to preserve and improve patient quality of life. Our lab is interested in studying the differential effects of radiation on oligodendrocyte cells, as they comprise the majority of white matter in the brain, and methods to halt radiation-induced damage. We have established a mass spectrometry-based metabolomics method to study radiation-injury in cells, tissue, and biofluids, and are applying this technique to study radiation effects on the MO3.13 oligodendrocyte cell line. We are currently investigating the ability of dimethyl fumarate (DMF), an established neuroprotective agent, to amend damage and demyelination to oligodendrocyte cells versus glioma cells, after X-irradiation. Using metabolomics, we noted that oligodendrocyte cells upregulated tricarboxylic acid (TCA) cycle intermediates in response to DMF treatment, with sustained levels after radiation. In addition, measured levels of glutathione were elevated, and markers for generalized oxidative stress were comparably lower with DMF pretreatment. Ultimately, this information could be used to prevent radiation-induced demyelination, promoting patient quality of life.
     
    Learning Objectives:
    • Understanding the current state of brain radiation treatment and patient outcomes and quality of life that can follow therapy.
    • Detailing basic glial cell biology, and how to use the MO3.13 cell line to model immature and mature differentiated oligodendrocyte cells.  
    • Understanding mass-spectrometry based metabolomics - and its use in monitoring markers of radiation injury, and oligodendrocyte metabolism.
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
      
     
     
     

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    AUG 15, 2019 9:00 AM PDT

    Understanding and ameliorating radiation-induced damage to oligodendrocytes


    Specialty

    Molecular Biology

    Cell Biology

    Cancer Research

    Immunology

    Biomarkers

    Genetics

    Biotechnology

    Cancer Therapeutics

    Biochemistry

    Dna

    Clinical Research

    Molecular Diagnostics

    Cell Culture

    Microbiology

    Cancer Diagnostics

    Geography

    North America68%

    Europe14%

    Asia13%

    South America2%

    Oceania2%

    Registration Source

    Website Visitors46%

    Email Promotions35%

    WAVE Newsletter Promotion6%

    Trending Newsletter Promotion3%

    Client/Sponsor Promotions1%

    Social Media Promotions1%

    Other8%

    Job Title

    Student15%

    Research Scientist14%

    Educator/Faculty13%

    Executive10%

    Medical Doctor/Specialist8%

    Facility/Department Manager8%

    Medical Laboratory Technician8%

    Clinical Laboratory Scientist7%

    Lab Management6%

    Scientist3%

    Chemist3%

    Post Doc3%

    Consultant2%

    Organization

    Academic Institution30%

    Hospital20%

    Research Institute7%

    Biotech Company4%

    Medical School4%

    Clinical Laboratory4%

    Medical Center3%

    Government3%

    Life Science Company2%

    Non-Profit Organization2%

    Independent Laboratories2%

    Consultant2%

    Pharmaceutical Company2%

    Industrial Company2%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more